<DOC>
	<DOC>NCT02133053</DOC>
	<brief_summary>This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray. The patient applies Ectoin® Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.</brief_summary>
	<brief_title>Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Diagnosed allergic rhinitis during the observational period Contra indications according to the label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Ectoine</keyword>
	<keyword>bitop</keyword>
	<keyword>Ectoin</keyword>
</DOC>